Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T22:33:33.134Z.
Calculation as of: 2026-10-06T22:33:33.134Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4b02f9201491092a18cecf2b81be2f5b28d52d90b5dbf9557ce71fef5bc65ed5
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Tvardi Therapeutics, Inc.
Market Cap
$10.13M
Free Cash Flow Yield
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD |
|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | $10.13M | N/A |
| Senti Biosciences, Inc. (SNTI)vs › | $10.06M | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.21M | N/A |
| Valion Bio, Inc. (VBIO)vs › | $9.86M | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.83M | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.45M | N/A |
| MetaVia Inc. (MTVA)vs › | $9.75M | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $9.71M | N/A |
| Pluri Inc. (PLUR)vs › | $10.68M | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
